Canagliflozin Targeting Vascular Inflammation

Clinical trial NCT05427084 · RECRUITING

Trial details

NCT number: NCT05427084
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetes Type 2 Coronary Artery Disease

Start date: 2024-11-15
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.